ALSTON & BIRD LLP lobbying for BIOMERIEUX, INC.

Filing Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Utah

Official filing document

Lobbyists on this filing 4

ALEXANDER GRAF New on this filing

Previously held: Deputy Assistant Secretary for Legislation, Department of Health and Human Services; Senate Finance Health Subcommittee Staff Director, Legislative Assistant, Legislative Aide, Deputy Scheduler, Staff Assistant, Senator Debbie Stabenow.
EVAN COLLIER New on this filing

Previously held: Legislative Correspondent and Staff Assistant, Rep. Jeff Denham.
JOSEPH BODDICKER New on this filing

Previously held: Tax Counsel, Senate Finance Cmte; Tax & Trade Counsel, Sen. Thune; Staff Dir., Senate Finance Subcmte on Tax; Tax Counsel/LA, Sen. Heller; Staff Dir., Senate Finance Subcmte on Energy; Finance Counsel, Sen. Gardner; LA/LC/SA, Sen. Thune.
JAMES PATRICK PALUSKIEWICZ New on this filing

Previously held: Chief Counsel, House Health Subcommittee; Professional Staff, House Energy & Commerce Committee; Legislative Dir./Deputy Chief of Staff, Rep. Michael Burgess; Legislative Dir., Rep. Charlie Norwood; Legislative Correspondent, Rep. Tubbs Jones.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 5

Budget/Appropriations

H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.

Health Issues

H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.

Medical/Disease Research/Clinical Labs

H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.

Medicare/Medicaid

H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.

Trade (domestic/foreign)

H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

BIOMERIEUX, S.A.

France · 69280 Marcy lEtoile · owns 100% of the client · contributed $0.00